XML 15 R5.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
True Up Costs December 2020
Avitide, Inc.
Common Stock
Common Stock
Avitide, Inc.
Additional Paid-In Capital
Additional Paid-In Capital
True Up Costs December 2020
Additional Paid-In Capital
Avitide, Inc.
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning Balance at Dec. 31, 2019 $ 1,059,768     $ 521   $ 1,068,431     $ (15,027) $ 5,843
Beginning Balance (in shares) at Dec. 31, 2019       52,078,258            
Net income 40,228                 40,228
Exercise of stock options and vesting of stock units 7,078     $ 5   7,073        
Exercise of stock options and vesting of stock units (in shares)       528,442            
Stock-based compensation expense 12,492         12,492        
Translation adjustment at Dec. 31, 2019 5,304               5,304  
Ending Balance at Sep. 30, 2020 1,124,870     $ 526   1,087,996     (9,723) 46,071
Ending Balance (in shares) at Sep. 30, 2020       52,606,700            
Beginning Balance at Jun. 30, 2020 1,100,027     $ 525   1,082,096     (14,113) 31,519
Beginning Balance (in shares) at Jun. 30, 2020       52,494,884            
Net income 14,552                 14,552
Exercise of stock options and vesting of stock units 1,676     $ 1   1,675        
Exercise of stock options and vesting of stock units (in shares)       111,816            
Stock-based compensation expense 4,225         4,225        
Translation adjustment at Jun. 30, 2020 4,390               4,390  
Ending Balance at Sep. 30, 2020 1,124,870     $ 526   1,087,996     (9,723) 46,071
Ending Balance (in shares) at Sep. 30, 2020       52,606,700            
Beginning Balance at Dec. 31, 2020 1,529,150     $ 548   1,460,748     2,085 65,769
Beginning Balance (in shares) at Dec. 31, 2020       54,760,837            
Net income 99,181                 99,181
Issuance of common stock for debt conversion 2     $ 0   2        
Issuance of common stock for debt conversion (in shares)       7            
Exercise of stock options and vesting of stock units 1,991     $ 2   1,989        
Exercise of stock options and vesting of stock units (in shares)       257,387            
Issuance of common stock   $ 145 $ 77,576   $ 3   $ 145 $ 77,573    
Issuance of commons stock (in shares)         271,096          
Tax withholding on vesting of restricted stock units (1,252)     $ 0   (1,252)        
Tax withholding on vesting of restricted stock units (in shares)       (5,339)            
Stock-based compensation expense 20,476         20,476        
Translation adjustment at Dec. 31, 2020 (12,004)               (12,004)  
Ending Balance at Sep. 30, 2021 1,715,265     $ 553   1,559,681     (9,919) 164,950
Ending Balance (in shares) at Sep. 30, 2021       55,283,988            
Beginning Balance at Jun. 30, 2021 1,603,069     $ 550   1,475,436     (4,369) 131,452
Beginning Balance (in shares) at Jun. 30, 2021       54,969,481            
Net income 33,498                 33,498
Issuance of common stock for debt conversion 1     $ 0   1        
Issuance of common stock for debt conversion (in shares)       4            
Exercise of stock options and vesting of stock units 1,131     $ 0   1,131        
Exercise of stock options and vesting of stock units (in shares)       48,746            
Issuance of common stock     $ 77,576   $ 3     $ 77,573    
Issuance of commons stock (in shares)         271,096          
Tax withholding on vesting of restricted stock units (1,252)     $ 0   (1,252)        
Tax withholding on vesting of restricted stock units (in shares)       (5,339)            
Stock-based compensation expense 6,792         6,792        
Translation adjustment at Jun. 30, 2021 (5,550)               (5,550)  
Ending Balance at Sep. 30, 2021 $ 1,715,265     $ 553   $ 1,559,681     $ (9,919) $ 164,950
Ending Balance (in shares) at Sep. 30, 2021       55,283,988